JP2002522041A - 腫瘍壊死因子γ - Google Patents

Info

Publication number

JP2002522041A

JP2002522041A JP2000563766A JP2000563766A JP2002522041A JP 2002522041 A JP2002522041 A JP 2002522041A JP 2000563766 A JP2000563766 A JP 2000563766A JP 2000563766 A JP2000563766 A JP 2000563766A JP 2002522041 A JP2002522041 A JP 2002522041A

Authority

JP

Japan

Prior art keywords

polypeptide

amino acid

tnf

acid sequence

seq

Prior art date

1998-08-07

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108060008682 Tumor Necrosis Factor Proteins 0.000 title description 13
• 102000003390 tumor necrosis factor Human genes 0.000 title description 3
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 707
• 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 688
• 229920001184 polypeptide Polymers 0.000 claims abstract description 661
• 238000000034 method Methods 0.000 claims abstract description 159
• 150000007523 nucleic acids Chemical group 0.000 claims abstract description 94
• 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 42
• 206010028980 Neoplasm Diseases 0.000 claims abstract description 40
• 238000010188 recombinant method Methods 0.000 claims abstract description 8
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 286
• 102000040430 polynucleotide Human genes 0.000 claims description 208
• 108091033319 polynucleotide Proteins 0.000 claims description 208
• 239000002157 polynucleotide Substances 0.000 claims description 208
• 210000004027 cell Anatomy 0.000 claims description 189
• 125000003729 nucleotide group Chemical group 0.000 claims description 159
• 239000002773 nucleotide Substances 0.000 claims description 157
• 239000002299 complementary DNA Substances 0.000 claims description 118
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 104
• 150000001413 amino acids Chemical class 0.000 claims description 96
• 102000039446 nucleic acids Human genes 0.000 claims description 77
• 108020004707 nucleic acids Proteins 0.000 claims description 77
• 239000013598 vector Substances 0.000 claims description 54
• 238000012217 deletion Methods 0.000 claims description 46
• 230000037430 deletion Effects 0.000 claims description 46
• 229930182817 methionine Natural products 0.000 claims description 31
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims description 28
• 230000000295 complement effect Effects 0.000 claims description 23
• 210000004899 c-terminal region Anatomy 0.000 claims description 20
• 238000004519 manufacturing process Methods 0.000 claims description 19
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 17
• 238000009396 hybridization Methods 0.000 claims description 13
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 9
• 238000012258 culturing Methods 0.000 claims description 3
• 108020004414 DNA Proteins 0.000 abstract description 58
• 239000005557 antagonist Substances 0.000 abstract description 42
• 241000282414 Homo sapiens Species 0.000 abstract description 39
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 28
• 201000010099 disease Diseases 0.000 abstract description 13
• 230000004663 cell proliferation Effects 0.000 abstract description 12
• 230000035772 mutation Effects 0.000 abstract description 12
• 230000001939 inductive effect Effects 0.000 abstract description 9
• 230000002401 inhibitory effect Effects 0.000 abstract description 9
• 208000015181 infectious disease Diseases 0.000 abstract description 8
• 230000035755 proliferation Effects 0.000 abstract description 8
• 206010003246 arthritis Diseases 0.000 abstract description 6
• 230000029663 wound healing Effects 0.000 abstract description 6
• 206010061218 Inflammation Diseases 0.000 abstract description 5
• 206010040070 Septic Shock Diseases 0.000 abstract description 5
• 230000004054 inflammatory process Effects 0.000 abstract description 5
• 206010063094 Cerebral malaria Diseases 0.000 abstract description 4
• 206010052779 Transplant rejections Diseases 0.000 abstract description 4
• 238000002405 diagnostic procedure Methods 0.000 abstract description 4
• 239000003814 drug Substances 0.000 abstract description 4
• 230000036303 septic shock Effects 0.000 abstract description 4
• 206010006895 Cachexia Diseases 0.000 abstract description 3
• 230000002757 inflammatory effect Effects 0.000 abstract description 3
• 230000002018 overexpression Effects 0.000 abstract description 3
• 208000037803 restenosis Diseases 0.000 abstract description 3
• 230000004936 stimulating effect Effects 0.000 abstract description 2
• 230000001737 promoting effect Effects 0.000 abstract 1
• 108090000623 proteins and genes Proteins 0.000 description 216
• 102000004169 proteins and genes Human genes 0.000 description 162
• 235000018102 proteins Nutrition 0.000 description 153
• 235000001014 amino acid Nutrition 0.000 description 136
• 239000012634 fragment Substances 0.000 description 118
• 229940024606 amino acid Drugs 0.000 description 94
• 125000000539 amino acid group Chemical group 0.000 description 83
• 230000014509 gene expression Effects 0.000 description 71
• 238000006467 substitution reaction Methods 0.000 description 60
• 102000005962 receptors Human genes 0.000 description 57
• 108020003175 receptors Proteins 0.000 description 57
• 230000027455 binding Effects 0.000 description 47
• 210000002889 endothelial cell Anatomy 0.000 description 45
• 230000000694 effects Effects 0.000 description 44
• 230000000890 antigenic effect Effects 0.000 description 38
• 206010054094 Tumour necrosis Diseases 0.000 description 35
• 230000002163 immunogen Effects 0.000 description 34
• 210000001519 tissue Anatomy 0.000 description 33
• 241001465754 Metazoa Species 0.000 description 31
• 238000003556 assay Methods 0.000 description 31
• 239000013612 plasmid Substances 0.000 description 31
• 238000001727 in vivo Methods 0.000 description 30
• 230000004071 biological effect Effects 0.000 description 26
• 239000003446 ligand Substances 0.000 description 25
• 230000001580 bacterial effect Effects 0.000 description 22
• 230000000875 corresponding effect Effects 0.000 description 22
• 239000013604 expression vector Substances 0.000 description 22
• 102000037865 fusion proteins Human genes 0.000 description 22
• 108020001507 fusion proteins Proteins 0.000 description 22
• 239000000556 agonist Substances 0.000 description 21
• 238000004458 analytical method Methods 0.000 description 21
• 108091026890 Coding region Proteins 0.000 description 20
• 230000001965 increasing effect Effects 0.000 description 20
• 108020004999 messenger RNA Proteins 0.000 description 18
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 17
• 241000700605 Viruses Species 0.000 description 17
• 239000000203 mixture Substances 0.000 description 17
• 238000003752 polymerase chain reaction Methods 0.000 description 17
• 230000015572 biosynthetic process Effects 0.000 description 16
• 108700019146 Transgenes Proteins 0.000 description 15
• 230000004913 activation Effects 0.000 description 15
• 230000033115 angiogenesis Effects 0.000 description 15
• 150000001875 compounds Chemical class 0.000 description 15
• 208000035475 disorder Diseases 0.000 description 15
• 108091034117 Oligonucleotide Proteins 0.000 description 14
• 238000007792 addition Methods 0.000 description 14
• 210000000349 chromosome Anatomy 0.000 description 14
• 238000005516 engineering process Methods 0.000 description 14
• 230000005714 functional activity Effects 0.000 description 14
• 239000013615 primer Substances 0.000 description 14
• 238000000746 purification Methods 0.000 description 14
• 239000000427 antigen Substances 0.000 description 13
• 229920001223 polyethylene glycol Polymers 0.000 description 13
• 230000009261 transgenic effect Effects 0.000 description 13
• 239000002202 Polyethylene glycol Substances 0.000 description 12
• 239000012472 biological sample Substances 0.000 description 12
• 230000002759 chromosomal effect Effects 0.000 description 12
• 230000006870 function Effects 0.000 description 12
• 230000001177 retroviral effect Effects 0.000 description 12
• 241000701447 unidentified baculovirus Species 0.000 description 12
• 238000007796 conventional method Methods 0.000 description 11
• 238000003745 diagnosis Methods 0.000 description 11
• 230000004927 fusion Effects 0.000 description 11
• 238000003018 immunoassay Methods 0.000 description 11
• 238000000338 in vitro Methods 0.000 description 11
• 210000004962 mammalian cell Anatomy 0.000 description 11
• 239000002609 medium Substances 0.000 description 11
• 230000008569 process Effects 0.000 description 11
• 230000001105 regulatory effect Effects 0.000 description 11
• 108091008146 restriction endonucleases Proteins 0.000 description 11
• 239000000523 sample Substances 0.000 description 11
• 239000000126 substance Substances 0.000 description 11
• 102100040247 Tumor necrosis factor Human genes 0.000 description 10
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 10
• 108091007433 antigens Proteins 0.000 description 10
• 102000036639 antigens Human genes 0.000 description 10
• 201000011510 cancer Diseases 0.000 description 10
• 230000001413 cellular effect Effects 0.000 description 10
• 210000003711 chorioallantoic membrane Anatomy 0.000 description 10
• 230000003993 interaction Effects 0.000 description 10
• 230000003834 intracellular effect Effects 0.000 description 10
• 239000003550 marker Substances 0.000 description 10
• 210000004379 membrane Anatomy 0.000 description 10
• 239000012528 membrane Substances 0.000 description 10
• 239000000047 product Substances 0.000 description 10
• 230000000717 retained effect Effects 0.000 description 10
• 239000007787 solid Substances 0.000 description 10
• 102000053602 DNA Human genes 0.000 description 9
• 241000588724 Escherichia coli Species 0.000 description 9
• 241000124008 Mammalia Species 0.000 description 9
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 9
• 238000003776 cleavage reaction Methods 0.000 description 9
• 238000001514 detection method Methods 0.000 description 9
• 230000012010 growth Effects 0.000 description 9
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 9
• 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 9
• 238000002360 preparation method Methods 0.000 description 9
• 230000007017 scission Effects 0.000 description 9
• 241000701161 unidentified adenovirus Species 0.000 description 9
• 108020005544 Antisense RNA Proteins 0.000 description 8
• 241000894006 Bacteria Species 0.000 description 8
• 241000238631 Hexapoda Species 0.000 description 8
• 230000000692 anti-sense effect Effects 0.000 description 8
• 230000008827 biological function Effects 0.000 description 8
• 210000001124 body fluid Anatomy 0.000 description 8
• 239000003184 complementary RNA Substances 0.000 description 8
• 239000003623 enhancer Substances 0.000 description 8
• 210000003527 eukaryotic cell Anatomy 0.000 description 8
• 238000003780 insertion Methods 0.000 description 8
• 230000037431 insertion Effects 0.000 description 8
• 238000013507 mapping Methods 0.000 description 8
• 239000000463 material Substances 0.000 description 8
• 230000010076 replication Effects 0.000 description 8
• 239000000243 solution Substances 0.000 description 8
• 238000013518 transcription Methods 0.000 description 8
• 230000035897 transcription Effects 0.000 description 8
• 238000013519 translation Methods 0.000 description 8
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 7
• 102000004190 Enzymes Human genes 0.000 description 7
• 108090000790 Enzymes Proteins 0.000 description 7
• HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 7
• 101000830596 Homo sapiens Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 description 7
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Natural products O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 7
• 102100024587 Tumor necrosis factor ligand superfamily member 15 Human genes 0.000 description 7
• 238000013459 approach Methods 0.000 description 7
• 239000010839 body fluid Substances 0.000 description 7
• 230000021164 cell adhesion Effects 0.000 description 7
• 238000004113 cell culture Methods 0.000 description 7
• 238000004587 chromatography analysis Methods 0.000 description 7
• 238000010367 cloning Methods 0.000 description 7
• 230000004069 differentiation Effects 0.000 description 7
• 229940088598 enzyme Drugs 0.000 description 7
• 239000000499 gel Substances 0.000 description 7
• 230000002068 genetic effect Effects 0.000 description 7
• 230000003394 haemopoietic effect Effects 0.000 description 7
• 230000002209 hydrophobic effect Effects 0.000 description 7
• 238000003384 imaging method Methods 0.000 description 7
• 230000001900 immune effect Effects 0.000 description 7
• 208000026278 immune system disease Diseases 0.000 description 7
• 239000000411 inducer Substances 0.000 description 7
• 230000001404 mediated effect Effects 0.000 description 7
• 239000002245 particle Substances 0.000 description 7
• 239000008194 pharmaceutical composition Substances 0.000 description 7
• 230000008488 polyadenylation Effects 0.000 description 7
• 230000004044 response Effects 0.000 description 7
• 238000003786 synthesis reaction Methods 0.000 description 7
• 230000001225 therapeutic effect Effects 0.000 description 7
• 238000011282 treatment Methods 0.000 description 7
• 230000009385 viral infection Effects 0.000 description 7
• 241000701022 Cytomegalovirus Species 0.000 description 6
• 241000282412 Homo Species 0.000 description 6
• 108060003951 Immunoglobulin Proteins 0.000 description 6
• 108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 6
• 108010076504 Protein Sorting Signals Proteins 0.000 description 6
• 108020004511 Recombinant DNA Proteins 0.000 description 6
• -1 aliphatic amino acid Chemical class 0.000 description 6
• 230000033228 biological regulation Effects 0.000 description 6
• 238000006243 chemical reaction Methods 0.000 description 6
• 238000004590 computer program Methods 0.000 description 6
• 102000018358 immunoglobulin Human genes 0.000 description 6
• 230000005764 inhibitory process Effects 0.000 description 6
• 238000002823 phage display Methods 0.000 description 6
• 238000012216 screening Methods 0.000 description 6
• 210000002966 serum Anatomy 0.000 description 6
• 238000001890 transfection Methods 0.000 description 6
• 230000003612 virological effect Effects 0.000 description 6
• 208000023275 Autoimmune disease Diseases 0.000 description 5
• 102000004127 Cytokines Human genes 0.000 description 5
• 108090000695 Cytokines Proteins 0.000 description 5
• 241000725303 Human immunodeficiency virus Species 0.000 description 5
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
• 241000699666 Mus <mouse, genus> Species 0.000 description 5
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 5
• 102000003945 NF-kappa B Human genes 0.000 description 5
• 108010057466 NF-kappa B Proteins 0.000 description 5
• 108700026244 Open Reading Frames Proteins 0.000 description 5
• 108091000080 Phosphotransferase Proteins 0.000 description 5
• 102000006601 Thymidine Kinase Human genes 0.000 description 5
• 108020004440 Thymidine kinase Proteins 0.000 description 5
• 208000036142 Viral infection Diseases 0.000 description 5
• 229960000723 ampicillin Drugs 0.000 description 5
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
• 238000004422 calculation algorithm Methods 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 210000002950 fibroblast Anatomy 0.000 description 5
• 238000002744 homologous recombination Methods 0.000 description 5
• 230000006801 homologous recombination Effects 0.000 description 5
• 230000003053 immunization Effects 0.000 description 5
• 238000002649 immunization Methods 0.000 description 5
• 230000004048 modification Effects 0.000 description 5
• 238000012986 modification Methods 0.000 description 5
• 102000020233 phosphotransferase Human genes 0.000 description 5
• 239000013600 plasmid vector Substances 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 238000012163 sequencing technique Methods 0.000 description 5
• 229940104230 thymidine Drugs 0.000 description 5
• 210000003606 umbilical vein Anatomy 0.000 description 5
• 241001430294 unidentified retrovirus Species 0.000 description 5
• 108020004491 Antisense DNA Proteins 0.000 description 4
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 4
• 208000024172 Cardiovascular disease Diseases 0.000 description 4
• 108020004705 Codon Proteins 0.000 description 4
• 238000001712 DNA sequencing Methods 0.000 description 4
• 238000012286 ELISA Assay Methods 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• 101710154606 Hemagglutinin Proteins 0.000 description 4
• 101000679903 Homo sapiens Tumor necrosis factor receptor superfamily member 25 Proteins 0.000 description 4
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 4
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
• 206010025323 Lymphomas Diseases 0.000 description 4
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
• 238000000636 Northern blotting Methods 0.000 description 4
• 108010038807 Oligopeptides Proteins 0.000 description 4
• 102000015636 Oligopeptides Human genes 0.000 description 4
• 241000283973 Oryctolagus cuniculus Species 0.000 description 4
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 4
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 4
• 241001111421 Pannus Species 0.000 description 4
• 101710182846 Polyhedrin Proteins 0.000 description 4
• 101710176177 Protein A56 Proteins 0.000 description 4
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
• 241000700584 Simplexvirus Species 0.000 description 4
• 108091081024 Start codon Proteins 0.000 description 4
• 210000001744 T-lymphocyte Anatomy 0.000 description 4
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
• 239000004473 Threonine Substances 0.000 description 4
• 102100022203 Tumor necrosis factor receptor superfamily member 25 Human genes 0.000 description 4
• 239000011543 agarose gel Substances 0.000 description 4
• 230000002788 anti-peptide Effects 0.000 description 4
• 239000003816 antisense DNA Substances 0.000 description 4
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 4
• 210000000988 bone and bone Anatomy 0.000 description 4
• 239000000872 buffer Substances 0.000 description 4
• 210000000845 cartilage Anatomy 0.000 description 4
• 230000003915 cell function Effects 0.000 description 4
• 239000013592 cell lysate Substances 0.000 description 4
• 238000005119 centrifugation Methods 0.000 description 4
• 239000003153 chemical reaction reagent Substances 0.000 description 4
• 238000012937 correction Methods 0.000 description 4
• 238000001212 derivatisation Methods 0.000 description 4
• 239000000539 dimer Substances 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 4
• 238000004520 electroporation Methods 0.000 description 4
• 239000001963 growth medium Substances 0.000 description 4
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 4
• 230000028993 immune response Effects 0.000 description 4
• 210000000987 immune system Anatomy 0.000 description 4
• 238000007901 in situ hybridization Methods 0.000 description 4
• 239000003112 inhibitor Substances 0.000 description 4
• 210000002540 macrophage Anatomy 0.000 description 4
• 239000000178 monomer Substances 0.000 description 4
• 230000003472 neutralizing effect Effects 0.000 description 4
• 244000045947 parasite Species 0.000 description 4
• 230000002062 proliferating effect Effects 0.000 description 4
• 238000003127 radioimmunoassay Methods 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 230000003248 secreting effect Effects 0.000 description 4
• 230000028327 secretion Effects 0.000 description 4
• 238000002864 sequence alignment Methods 0.000 description 4
• 241000894007 species Species 0.000 description 4
• 230000009466 transformation Effects 0.000 description 4
• 210000002700 urine Anatomy 0.000 description 4
• FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 3
• 206010006187 Breast cancer Diseases 0.000 description 3
• 208000026310 Breast neoplasm Diseases 0.000 description 3
• 102000014914 Carrier Proteins Human genes 0.000 description 3
• 102000000844 Cell Surface Receptors Human genes 0.000 description 3
• 108010001857 Cell Surface Receptors Proteins 0.000 description 3
• 108020004635 Complementary DNA Proteins 0.000 description 3
• 239000003155 DNA primer Substances 0.000 description 3
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 3
• 238000002965 ELISA Methods 0.000 description 3
• 241000196324 Embryophyta Species 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 101100005713 Homo sapiens CD4 gene Proteins 0.000 description 3
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
• 238000012300 Sequence Analysis Methods 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 3
• 230000002159 abnormal effect Effects 0.000 description 3
• 230000009471 action Effects 0.000 description 3
• QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• 230000005875 antibody response Effects 0.000 description 3
• 230000006907 apoptotic process Effects 0.000 description 3
• 238000001574 biopsy Methods 0.000 description 3
• 210000004204 blood vessel Anatomy 0.000 description 3
• 230000037396 body weight Effects 0.000 description 3
• 238000009395 breeding Methods 0.000 description 3
• 230000001488 breeding effect Effects 0.000 description 3
• 230000010261 cell growth Effects 0.000 description 3
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
• 230000007423 decrease Effects 0.000 description 3
• 230000007123 defense Effects 0.000 description 3
• 239000005547 deoxyribonucleotide Substances 0.000 description 3
• 230000029087 digestion Effects 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 210000001671 embryonic stem cell Anatomy 0.000 description 3
• 230000002496 gastric effect Effects 0.000 description 3
• 238000001415 gene therapy Methods 0.000 description 3
• 230000013595 glycosylation Effects 0.000 description 3
• 238000006206 glycosylation reaction Methods 0.000 description 3
• 229960004198 guanidine Drugs 0.000 description 3
• PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 3
• 239000000710 homodimer Substances 0.000 description 3
• 210000003917 human chromosome Anatomy 0.000 description 3
• 210000004408 hybridoma Anatomy 0.000 description 3
• 230000005847 immunogenicity Effects 0.000 description 3
• 238000010348 incorporation Methods 0.000 description 3
• 238000011534 incubation Methods 0.000 description 3
• 230000006698 induction Effects 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• 230000010354 integration Effects 0.000 description 3
• 230000000968 intestinal effect Effects 0.000 description 3
• 230000009545 invasion Effects 0.000 description 3
• 101150109249 lacI gene Proteins 0.000 description 3
• 208000032839 leukemia Diseases 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 201000001441 melanoma Diseases 0.000 description 3
• 230000014399 negative regulation of angiogenesis Effects 0.000 description 3
• 230000010046 negative regulation of endothelial cell proliferation Effects 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 201000008482 osteoarthritis Diseases 0.000 description 3
• 238000004806 packaging method and process Methods 0.000 description 3
• 210000002381 plasma Anatomy 0.000 description 3
• 229920002401 polyacrylamide Polymers 0.000 description 3
• 229920000642 polymer Polymers 0.000 description 3
• 230000006337 proteolytic cleavage Effects 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 210000001179 synovial fluid Anatomy 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 230000014621 translational initiation Effects 0.000 description 3
• 239000013638 trimer Substances 0.000 description 3
• 230000004614 tumor growth Effects 0.000 description 3
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 3
• 239000013603 viral vector Substances 0.000 description 3
• 210000005253 yeast cell Anatomy 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• 230000006269 (delayed) early viral mRNA transcription Effects 0.000 description 2
• NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 2
• 208000003200 Adenoma Diseases 0.000 description 2
• 229920001817 Agar Polymers 0.000 description 2
• 102400000068 Angiostatin Human genes 0.000 description 2
• 108010079709 Angiostatins Proteins 0.000 description 2
• 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 2
• 208000006386 Bone Resorption Diseases 0.000 description 2
• 206010065553 Bone marrow failure Diseases 0.000 description 2
• 102000001902 CC Chemokines Human genes 0.000 description 2
• 108010040471 CC Chemokines Proteins 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 201000009030 Carcinoma Diseases 0.000 description 2
• 241000700199 Cavia porcellus Species 0.000 description 2
• 241000282693 Cercopithecidae Species 0.000 description 2
• 108050000299 Chemokine receptor Proteins 0.000 description 2
• 102000009410 Chemokine receptor Human genes 0.000 description 2
• 108091033380 Coding strand Proteins 0.000 description 2
• 108010062580 Concanavalin A Proteins 0.000 description 2
• 102000012410 DNA Ligases Human genes 0.000 description 2
• 108010061982 DNA Ligases Proteins 0.000 description 2
• 229920002307 Dextran Polymers 0.000 description 2
• 108010042407 Endonucleases Proteins 0.000 description 2
• 241000206602 Eukaryota Species 0.000 description 2
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
• 201000008808 Fibrosarcoma Diseases 0.000 description 2
• 241000287828 Gallus gallus Species 0.000 description 2
• 208000007569 Giant Cell Tumors Diseases 0.000 description 2
• 208000009329 Graft vs Host Disease Diseases 0.000 description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• 108010078321 Guanylate Cyclase Proteins 0.000 description 2
• 102000014469 Guanylate cyclase Human genes 0.000 description 2
• 208000031886 HIV Infections Diseases 0.000 description 2
• 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 2
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
• 206010062016 Immunosuppression Diseases 0.000 description 2
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• 102000000589 Interleukin-1 Human genes 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• 102000004889 Interleukin-6 Human genes 0.000 description 2
• 108010063738 Interleukins Proteins 0.000 description 2
• 102000015696 Interleukins Human genes 0.000 description 2
• 102000004310 Ion Channels Human genes 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• 208000008771 Lymphadenopathy Diseases 0.000 description 2
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 2
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 2
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 241000713869 Moloney murine leukemia virus Species 0.000 description 2
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
• 238000005481 NMR spectroscopy Methods 0.000 description 2
• 206010029260 Neuroblastoma Diseases 0.000 description 2
• 101710163270 Nuclease Proteins 0.000 description 2
• 208000001715 Osteoblastoma Diseases 0.000 description 2
• 108091006006 PEGylated Proteins Proteins 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 108090000526 Papain Proteins 0.000 description 2
• 208000034038 Pathologic Neovascularization Diseases 0.000 description 2
• 239000004793 Polystyrene Substances 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 201000000582 Retinoblastoma Diseases 0.000 description 2
• 108091028664 Ribonucleotide Proteins 0.000 description 2
• 238000002105 Southern blotting Methods 0.000 description 2
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
• 108010092262 T-Cell Antigen Receptors Proteins 0.000 description 2
• 102100023132 Transcription factor Jun Human genes 0.000 description 2
• 102100032236 Tumor necrosis factor receptor superfamily member 11B Human genes 0.000 description 2
• 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 2
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
• 206010046798 Uterine leiomyoma Diseases 0.000 description 2
• 108020005202 Viral DNA Proteins 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 239000008272 agar Substances 0.000 description 2
• 238000007818 agglutination assay Methods 0.000 description 2
• 230000002776 aggregation Effects 0.000 description 2
• 238000004220 aggregation Methods 0.000 description 2
• 239000002870 angiogenesis inducing agent Substances 0.000 description 2
• 230000002491 angiogenic effect Effects 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 230000000259 anti-tumor effect Effects 0.000 description 2
• 238000003782 apoptosis assay Methods 0.000 description 2
• FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 2
• 230000005784 autoimmunity Effects 0.000 description 2
• UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 210000002459 blastocyst Anatomy 0.000 description 2
• 230000000903 blocking effect Effects 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 230000024279 bone resorption Effects 0.000 description 2
• 210000000481 breast Anatomy 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 230000009134 cell regulation Effects 0.000 description 2
• 230000036755 cellular response Effects 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 239000013522 chelant Substances 0.000 description 2
• 238000007385 chemical modification Methods 0.000 description 2
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
• 230000004087 circulation Effects 0.000 description 2
• 238000005352 clarification Methods 0.000 description 2
• 239000013599 cloning vector Substances 0.000 description 2
• 210000001072 colon Anatomy 0.000 description 2
• 238000012875 competitive assay Methods 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 229960002086 dextran Drugs 0.000 description 2
• 210000002257 embryonic structure Anatomy 0.000 description 2
• 230000003511 endothelial effect Effects 0.000 description 2
• 230000001747 exhibiting effect Effects 0.000 description 2
• 229940126864 fibroblast growth factor Drugs 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
• 238000001502 gel electrophoresis Methods 0.000 description 2
• 238000010363 gene targeting Methods 0.000 description 2
• 208000005017 glioblastoma Diseases 0.000 description 2
• 208000024908 graft versus host disease Diseases 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• 210000002216 heart Anatomy 0.000 description 2
• 239000000185 hemagglutinin Substances 0.000 description 2
• 230000011132 hemopoiesis Effects 0.000 description 2
• 210000004754 hybrid cell Anatomy 0.000 description 2
• 230000001506 immunosuppresive effect Effects 0.000 description 2
• 230000000686 immunotropic effect Effects 0.000 description 2
• 230000000415 inactivating effect Effects 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 210000004969 inflammatory cell Anatomy 0.000 description 2
• 206010022000 influenza Diseases 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
• 238000005304 joining Methods 0.000 description 2
• 229960000318 kanamycin Drugs 0.000 description 2
• 229930027917 kanamycin Natural products 0.000 description 2
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
• 229930182823 kanamycin A Natural products 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 201000010260 leiomyoma Diseases 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 208000018555 lymphatic system disease Diseases 0.000 description 2
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 238000002844 melting Methods 0.000 description 2
• 230000008018 melting Effects 0.000 description 2
• 230000002503 metabolic effect Effects 0.000 description 2
• DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
• 210000000822 natural killer cell Anatomy 0.000 description 2
• 229910052759 nickel Inorganic materials 0.000 description 2
• 235000015097 nutrients Nutrition 0.000 description 2
• 229940055729 papain Drugs 0.000 description 2
• 235000019834 papain Nutrition 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 150000003906 phosphoinositides Chemical class 0.000 description 2
• 229910052698 phosphorus Inorganic materials 0.000 description 2
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
• 229920002223 polystyrene Polymers 0.000 description 2
• 239000002987 primer (paints) Substances 0.000 description 2
• 210000001236 prokaryotic cell Anatomy 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
• 238000012340 reverse transcriptase PCR Methods 0.000 description 2
• 238000010839 reverse transcription Methods 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 239000002336 ribonucleotide Substances 0.000 description 2
• 125000002652 ribonucleotide group Chemical group 0.000 description 2
• FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
• 238000004062 sedimentation Methods 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• 230000019491 signal transduction Effects 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
• 238000010532 solid phase synthesis reaction Methods 0.000 description 2
• 125000006850 spacer group Chemical group 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 210000000130 stem cell Anatomy 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 230000002381 testicular Effects 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• 230000009452 underexpressoin Effects 0.000 description 2
• 230000002792 vascular Effects 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• BVAUMRCGVHUWOZ-ZETCQYMHSA-N (2s)-2-(cyclohexylazaniumyl)propanoate Chemical compound OC(=O)[C@H](C)NC1CCCCC1 BVAUMRCGVHUWOZ-ZETCQYMHSA-N 0.000 description 1
• MRTPISKDZDHEQI-YFKPBYRVSA-N (2s)-2-(tert-butylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC(C)(C)C MRTPISKDZDHEQI-YFKPBYRVSA-N 0.000 description 1
• NPDBDJFLKKQMCM-SCSAIBSYSA-N (2s)-2-amino-3,3-dimethylbutanoic acid Chemical compound CC(C)(C)[C@H](N)C(O)=O NPDBDJFLKKQMCM-SCSAIBSYSA-N 0.000 description 1
• 101150084750 1 gene Proteins 0.000 description 1
• GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
• CXCHEKCRJQRVNG-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonyl chloride Chemical compound FC(F)(F)CS(Cl)(=O)=O CXCHEKCRJQRVNG-UHFFFAOYSA-N 0.000 description 1
• OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
• OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
• SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• 102000013563 Acid Phosphatase Human genes 0.000 description 1
• 108010051457 Acid Phosphatase Proteins 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 108010032595 Antibody Binding Sites Proteins 0.000 description 1
• 101100238293 Arabidopsis thaliana MOR1 gene Proteins 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 238000012935 Averaging Methods 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 244000063299 Bacillus subtilis Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 108700011778 CCR5 Proteins 0.000 description 1
• 102100027207 CD27 antigen Human genes 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 101100228206 Caenorhabditis elegans gly-6 gene Proteins 0.000 description 1
• 241000282836 Camelus dromedarius Species 0.000 description 1
• 241000282461 Canis lupus Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 208000005623 Carcinogenesis Diseases 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
• 241000905957 Channa melasoma Species 0.000 description 1
• 102000001327 Chemokine CCL5 Human genes 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 229940122444 Chemokine receptor antagonist Drugs 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 108090000317 Chymotrypsin Proteins 0.000 description 1
• 108091062157 Cis-regulatory element Proteins 0.000 description 1
• 102100031162 Collagen alpha-1(XVIII) chain Human genes 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 241000450599 DNA viruses Species 0.000 description 1
• 101100096502 Danio rerio spring gene Proteins 0.000 description 1
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 108010024212 E-Selectin Proteins 0.000 description 1
• 102100023471 E-selectin Human genes 0.000 description 1
• 102100031780 Endonuclease Human genes 0.000 description 1
• 102000004533 Endonucleases Human genes 0.000 description 1
• 108010079505 Endostatins Proteins 0.000 description 1
• 241000709661 Enterovirus Species 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 241000701959 Escherichia virus Lambda Species 0.000 description 1
• 101150064015 FAS gene Proteins 0.000 description 1
• 101150019331 FGF2 gene Proteins 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
• 206010016654 Fibrosis Diseases 0.000 description 1
• 241000724791 Filamentous phage Species 0.000 description 1
• 230000005526 G1 to G0 transition Effects 0.000 description 1
• 108010093031 Galactosidases Proteins 0.000 description 1
• 101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 229930182566 Gentamicin Natural products 0.000 description 1
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
• 241000713813 Gibbon ape leukemia virus Species 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000004366 Glucose oxidase Substances 0.000 description 1
• 108010015776 Glucose oxidase Proteins 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 108010051815 Glutamyl endopeptidase Proteins 0.000 description 1
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 230000010556 Heparin Binding Activity Effects 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
• 108010033040 Histones Proteins 0.000 description 1
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
• 101000764294 Homo sapiens Lymphotoxin-beta Proteins 0.000 description 1
• 101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 description 1
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
• 101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 1
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
• 102000002265 Human Growth Hormone Human genes 0.000 description 1
• 108010000521 Human Growth Hormone Proteins 0.000 description 1
• 239000000854 Human Growth Hormone Substances 0.000 description 1
• 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
• 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 208000029462 Immunodeficiency disease Diseases 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
• 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• XIGSAGMEBXLVJJ-YFKPBYRVSA-N L-homocitrulline Chemical compound NC(=O)NCCCC[C@H]([NH3+])C([O-])=O XIGSAGMEBXLVJJ-YFKPBYRVSA-N 0.000 description 1
• SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
• 229930186657 Lat Natural products 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
• 102100022119 Lipoprotein lipase Human genes 0.000 description 1
• 108010047357 Luminescent Proteins Proteins 0.000 description 1
• 102000006830 Luminescent Proteins Human genes 0.000 description 1
• 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 description 1
• 101000969137 Mus musculus Metallothionein-1 Proteins 0.000 description 1
• 101100096504 Mus musculus Spring1 gene Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 108010021466 Mutant Proteins Proteins 0.000 description 1
• 102000008300 Mutant Proteins Human genes 0.000 description 1
• 241000713883 Myeloproliferative sarcoma virus Species 0.000 description 1
• BKAYIFDRRZZKNF-VIFPVBQESA-N N-acetylcarnosine Chemical compound CC(=O)NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BKAYIFDRRZZKNF-VIFPVBQESA-N 0.000 description 1
• 230000004988 N-glycosylation Effects 0.000 description 1
• 108091061960 Naked DNA Proteins 0.000 description 1
• RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 206010029113 Neovascularisation Diseases 0.000 description 1
• 108091092724 Noncoding DNA Proteins 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 241001024099 Olla Species 0.000 description 1
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
• 208000001132 Osteoporosis Diseases 0.000 description 1
• 108010035042 Osteoprotegerin Proteins 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
• 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
• 241000282520 Papio Species 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 241000237988 Patellidae Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 102000003992 Peroxidases Human genes 0.000 description 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
• 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 1
• 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 1
• 102000004211 Platelet factor 4 Human genes 0.000 description 1
• 108090000778 Platelet factor 4 Proteins 0.000 description 1
• 241001337451 Polyblastus cancer Species 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 241000125945 Protoparvovirus Species 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 239000012083 RIPA buffer Substances 0.000 description 1
• 108091034057 RNA (poly(A)) Proteins 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 101100426090 Rattus norvegicus Trim9 gene Proteins 0.000 description 1
• 241000702263 Reovirus sp. Species 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 101100379247 Salmo trutta apoa1 gene Proteins 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 108010077895 Sarcosine Proteins 0.000 description 1
• 241000555745 Sciuridae Species 0.000 description 1
• 206010040047 Sepsis Diseases 0.000 description 1
• 241000713896 Spleen necrosis virus Species 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 230000006044 T cell activation Effects 0.000 description 1
• 230000006052 T cell proliferation Effects 0.000 description 1
• 101150006914 TRP1 gene Proteins 0.000 description 1
• GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 208000007536 Thrombosis Diseases 0.000 description 1
• 102000002938 Thrombospondin Human genes 0.000 description 1
• 108060008245 Thrombospondin Proteins 0.000 description 1
• 102000004357 Transferases Human genes 0.000 description 1
• 108090000992 Transferases Proteins 0.000 description 1
• YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
• 108090000631 Trypsin Proteins 0.000 description 1
• 102000004142 Trypsin Human genes 0.000 description 1
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
• 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 1
• 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
• YJQCOFNZVFGCAF-UHFFFAOYSA-N Tunicamycin II Natural products O1C(CC(O)C2C(C(O)C(O2)N2C(NC(=O)C=C2)=O)O)C(O)C(O)C(NC(=O)C=CCCCCCCCCC(C)C)C1OC1OC(CO)C(O)C(O)C1NC(C)=O YJQCOFNZVFGCAF-UHFFFAOYSA-N 0.000 description 1
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
• 108091005956 Type II transmembrane proteins Proteins 0.000 description 1
• 108091023045 Untranslated Region Proteins 0.000 description 1
• 229910052770 Uranium Inorganic materials 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 1
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
• 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 108070000030 Viral receptors Proteins 0.000 description 1
• 101100096505 Xenopus laevis spring1 gene Proteins 0.000 description 1
• HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 230000002730 additional effect Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 210000001789 adipocyte Anatomy 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• 239000007801 affinity label Substances 0.000 description 1
• 238000001261 affinity purification Methods 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 238000012867 alanine scanning Methods 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000001408 amides Chemical group 0.000 description 1
• 229960002684 aminocaproic acid Drugs 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 239000004037 angiogenesis inhibitor Substances 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000005571 anion exchange chromatography Methods 0.000 description 1
• 150000001450 anions Chemical class 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 239000002260 anti-inflammatory agent Substances 0.000 description 1
• 229940121363 anti-inflammatory agent Drugs 0.000 description 1
• 230000003110 anti-inflammatory effect Effects 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 210000002403 aortic endothelial cell Anatomy 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 201000009361 ascariasis Diseases 0.000 description 1
• 230000003305 autocrine Effects 0.000 description 1
• 238000011888 autopsy Methods 0.000 description 1
• 238000000376 autoradiography Methods 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 229910052788 barium Inorganic materials 0.000 description 1
• DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 230000017531 blood circulation Effects 0.000 description 1
• 230000023555 blood coagulation Effects 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 210000002798 bone marrow cell Anatomy 0.000 description 1
• 239000012888 bovine serum Substances 0.000 description 1
• 210000000424 bronchial epithelial cell Anatomy 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 229910052792 caesium Inorganic materials 0.000 description 1
• TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 230000036952 cancer formation Effects 0.000 description 1
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 238000005277 cation exchange chromatography Methods 0.000 description 1
• 230000011712 cell development Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 230000006041 cell recruitment Effects 0.000 description 1
• 108091092328 cellular RNA Proteins 0.000 description 1
• 230000003196 chaotropic effect Effects 0.000 description 1
• 239000002559 chemokine receptor antagonist Substances 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000003837 chick embryo Anatomy 0.000 description 1
• 229960005091 chloramphenicol Drugs 0.000 description 1
• 238000003200 chromosome mapping Methods 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 229960002376 chymotrypsin Drugs 0.000 description 1
• 230000007882 cirrhosis Effects 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• 229960002173 citrulline Drugs 0.000 description 1
• 235000013477 citrulline Nutrition 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 230000006957 competitive inhibition Effects 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 230000009260 cross reactivity Effects 0.000 description 1
• 239000011243 crosslinked material Substances 0.000 description 1
• 239000000287 crude extract Substances 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000005860 defense response to virus Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 238000000151 deposition Methods 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 229910052805 deuterium Inorganic materials 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 229960000633 dextran sulfate Drugs 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• 238000006471 dimerization reaction Methods 0.000 description 1
• 208000037765 diseases and disorders Diseases 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 210000002308 embryonic cell Anatomy 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 210000003038 endothelium Anatomy 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 238000012869 ethanol precipitation Methods 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 238000001400 expression cloning Methods 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000012894 fetal calf serum Substances 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 230000020764 fibrinolysis Effects 0.000 description 1
• 230000003176 fibrotic effect Effects 0.000 description 1
• 239000012847 fine chemical Substances 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 230000022244 formylation Effects 0.000 description 1
• 238000006170 formylation reaction Methods 0.000 description 1
• 230000037433 frameshift Effects 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
• 238000012817 gel-diffusion technique Methods 0.000 description 1
• 238000002523 gelfiltration Methods 0.000 description 1
• 101150056310 gem1 gene Proteins 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 229960002518 gentamicin Drugs 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 239000003365 glass fiber Substances 0.000 description 1
• 102000018146 globin Human genes 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 229940116332 glucose oxidase Drugs 0.000 description 1
• 235000019420 glucose oxidase Nutrition 0.000 description 1
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
• 230000002414 glycolytic effect Effects 0.000 description 1
• 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 239000006451 grace's insect medium Substances 0.000 description 1
• 239000011544 gradient gel Substances 0.000 description 1
• 230000035931 haemagglutination Effects 0.000 description 1
• 210000000777 hematopoietic system Anatomy 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 239000000833 heterodimer Substances 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• 230000005745 host immune response Effects 0.000 description 1
• 102000055414 human LTB Human genes 0.000 description 1
• 102000057041 human TNF Human genes 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000003301 hydrolyzing effect Effects 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
• 229960002591 hydroxyproline Drugs 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 230000007813 immunodeficiency Effects 0.000 description 1
• 230000000951 immunodiffusion Effects 0.000 description 1
• 238000000760 immunoelectrophoresis Methods 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 239000003547 immunosorbent Substances 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000003017 in situ immunoassay Methods 0.000 description 1
• 238000010249 in-situ analysis Methods 0.000 description 1
• 229910052738 indium Inorganic materials 0.000 description 1
• APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
• 230000006882 induction of apoptosis Effects 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 208000027866 inflammatory disease Diseases 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 230000026045 iodination Effects 0.000 description 1
• 238000006192 iodination reaction Methods 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• 239000011630 iodine Substances 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 101150085091 lat-2 gene Proteins 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 238000007834 ligase chain reaction Methods 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 238000001638 lipofection Methods 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 208000003747 lymphoid leukemia Diseases 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 230000031864 metaphase Effects 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000003226 mitogen Substances 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 239000002808 molecular sieve Substances 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 210000003097 mucus Anatomy 0.000 description 1
• 210000000663 muscle cell Anatomy 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 210000003098 myoblast Anatomy 0.000 description 1
• 208000009091 myxoma Diseases 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 108091027963 non-coding RNA Proteins 0.000 description 1
• 102000042567 non-coding RNA Human genes 0.000 description 1
• 230000036963 noncompetitive effect Effects 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 1
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 210000000287 oocyte Anatomy 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 229960003104 ornithine Drugs 0.000 description 1
• 238000009401 outcrossing Methods 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 210000002741 palatine tonsil Anatomy 0.000 description 1
• 238000004091 panning Methods 0.000 description 1
• 230000003071 parasitic effect Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 239000013610 patient sample Substances 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 210000001322 periplasm Anatomy 0.000 description 1
• 210000004786 perivascular cell Anatomy 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• 238000002205 phenol-chloroform extraction Methods 0.000 description 1
• 229940080469 phosphocellulose Drugs 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 230000004983 pleiotropic effect Effects 0.000 description 1
• 210000001778 pluripotent stem cell Anatomy 0.000 description 1
• 102000054765 polymorphisms of proteins Human genes 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 230000030114 positive regulation of endothelial cell proliferation Effects 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 244000144977 poultry Species 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 238000004393 prognosis Methods 0.000 description 1
• 230000005522 programmed cell death Effects 0.000 description 1
• 230000009696 proliferative response Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 238000013197 protein A assay Methods 0.000 description 1
• 238000011092 protein amplification Methods 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 230000003946 protein process Effects 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 208000009305 pseudorabies Diseases 0.000 description 1
• 208000005069 pulmonary fibrosis Diseases 0.000 description 1
• 239000012264 purified product Substances 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 238000000163 radioactive labelling Methods 0.000 description 1
• 238000002601 radiography Methods 0.000 description 1
• 108700008711 rat Tro Proteins 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 230000001603 reducing effect Effects 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 230000026267 regulation of growth Effects 0.000 description 1
• 230000008844 regulatory mechanism Effects 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• 210000003935 rough endoplasmic reticulum Anatomy 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 229940043230 sarcosine Drugs 0.000 description 1
• 238000013341 scale-up Methods 0.000 description 1
• 201000004409 schistosomiasis Diseases 0.000 description 1
• 238000005204 segregation Methods 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
• 208000015891 sexual disease Diseases 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• SQMCFUSVGSBKFK-UHFFFAOYSA-M sodium;5-(cyclohexen-1-yl)-1,5-dimethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].O=C1N(C)C(=O)[N-]C(=O)C1(C)C1=CCCCC1 SQMCFUSVGSBKFK-UHFFFAOYSA-M 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 210000002536 stromal cell Anatomy 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 210000003523 substantia nigra Anatomy 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 210000002437 synoviocyte Anatomy 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 238000011191 terminal modification Methods 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 229960000814 tetanus toxoid Drugs 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 229940126585 therapeutic drug Drugs 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 102000027257 transmembrane receptors Human genes 0.000 description 1
• 108091008578 transmembrane receptors Proteins 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 208000003982 trichinellosis Diseases 0.000 description 1
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
• 229940038773 trisodium citrate Drugs 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 229910052722 tritium Inorganic materials 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• 229960001322 trypsin Drugs 0.000 description 1
• 230000005747 tumor angiogenesis Effects 0.000 description 1
• 230000004565 tumor cell growth Effects 0.000 description 1
• ZHSGGJXRNHWHRS-VIDYELAYSA-N tunicamycin Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](O)[C@@H](CC(O)[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C(NC(=O)C=C2)=O)O)O1)O)NC(=O)/C=C/CC(C)C)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O ZHSGGJXRNHWHRS-VIDYELAYSA-N 0.000 description 1
• MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
• 229940045145 uridine Drugs 0.000 description 1
• 230000006444 vascular growth Effects 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 230000007332 vesicle formation Effects 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 229920003169 water-soluble polymer Polymers 0.000 description 1